share_log

Valneva盘前暴涨超30%,旗下在研新冠疫苗3期试验取得积极结果

Valneva skyrocketed more than 30% before the opening, and its phase 3 trial of COVID-19 vaccine achieved positive results.

新浪美股 ·  Oct 18, 2021 04:23

Valneva (VALN.N) soared more than 30% before the market, and its phase 3 trial of COVID-19 vaccine has achieved positive results.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment